A risk stratification model for high-flow nasal cannula use in patients with coronavirus disease 2019 in Japan: A single-center retrospective observational cohort study.
<h4>Background</h4>The coronavirus disease 2019 (COVID-19) pandemic has put a strain on the healthcare system, and sudden changes in disease status during home treatment have become a serious issue. Therefore, prediction of disease severity and allocation of sufficient medical resources,...
Main Authors: | Ibuki Kurihara, Hitoshi Sugawara |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0290937 |
Similar Items
-
External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan
by: Hiromu Okano, et al.
Published: (2024-02-01) -
Stratification of COVID-19 Patients with Moderate-to-Severe Hypoxemic Respiratory Failure for Response to High-Flow Nasal Cannula: A Retrospective Observational Study
by: Gianluca Bagnato, et al.
Published: (2023-12-01) -
Comparison of high-flow nasal cannula and conventional nasal cannula during sedation for endoscopic submucosal dissection: a retrospective study
by: Seungwon Lee, et al.
Published: (2023-08-01) -
Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study
by: Ryosuke Hirabayashi, et al.
Published: (2023-08-01) -
High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study.
by: Pieter Veenstra, et al.
Published: (2022-01-01)